Rivo Yudhinata Brian Nugraha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rivo Yudhinata Brian Nugraha has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Loeki Enggar Fitri
Department of Clinical Parasitology, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia
4 shared publications - Ajeng Maharani Putri
Univ Brawijaya, Fac Med, Malaria Res Grp, Malang 65145, East Java, Indonesia
2 shared publications - Alfian Wika Cahyono
Doctoral Program in Medical Science, Faculty of Medicine, Universitas Brawijaya, Malang 65145, East Java, Indonesia
2 shared publications - Dio Giovanni Ariel
Study Program of Pharmacy, Faculty of Medicine, Universitas Brawijaya Malang
2 shared publications - Fitria Febriliani Putri
Study Program of Pharmacy, Faculty of Medicine, Universitas Brawijaya Malang
2 shared publications - Icha Farihah Deniyati Faratisha
Master Program in Biomedical Science, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia
2 shared publications
Latest Publications
- 15 June 2026
- Published by Termedia Sp. z.o.o. in BioTechnologia
Evaluation of humoral and cellular immune responses induced by a novel YidRv subunit vaccine from hypervirulent Klebsiella pneumoniae
Background: Klebsiella pneumoniae (KP) has re-emerged as a prominent etiological agent of pneumonia and systemic infection, with extended-spectrum β-lactamase (ESBL)-producing strains posing considerable therapeutic challenges. Moreover, vaccines may have limited efficacy because of the emergence of variant strains. The yidRv gene encodes a protein linked to excessive adherence and is conserved in over 99% of KP isolates. The present study aimed to explore the ability of a rec-YidRv protein to stimulate humoral and cellular immune response in vitro and in vivo. Material and methods: The capability of the purified rec-YidRv protein to induce antibody synthesis was tested using a mice model. We also assessed whether rec-YidRv could successfully trigger the proliferation of splenocytes and the synthesis of their cytokines. Furthermore, the capacity of antigen to protect mice from ESBL-producing KP strain infection was investigated. Results: In vitro and in vivo analyses revealed that mice immunized with rec-YidRv generated a strong antibody and memory response. Compared to non-stimulated controls, immunized mice showed an increase in measurable KP-directed immunoglobulin G (IgG) levels, with elevated IgG1 and IgG2b fractions; additionally, splenocyte proliferation expanded by 5-fold. Infection of mice with a lethal dose of KP following immunization markedly extended animal survival and decreased the pathogen’s ability to form ventricular biofilms. Conclusions: The rec-YidRv elicited robust antibody responses and a moderate expansion of cellular activity. Rec-YidRv is an effective protein-only platform for inhibiting infection by antibiotic-resistant KP. Future studies should incorporate refined adjuvants and improved administration methods to enhance protective responses.
- 15 June 2026
- Published by Termedia Sp. z.o.o. in BioTechnologia
Evaluation of humoral and cellular immune responses induced by a novel YidRv subunit vaccine from hypervirulent Klebsiella pneumoniae
Background: Klebsiella pneumoniae (KP) has re-emerged as a prominent etiological agent of pneumonia and systemic infection, with extended-spectrum β-lactamase (ESBL)-producing strains posing considerable therapeutic challenges. Moreover, vaccines may have limited efficacy because of the emergence of variant strains. The yidRv gene encodes a protein linked to excessive adherence and is conserved in over 99% of KP isolates. The present study aimed to explore the ability of a rec-YidRv protein to stimulate humoral and cellular immune response in vitro and in vivo. Material and methods: The capability of the purified rec-YidRv protein to induce antibody synthesis was tested using a mice model. We also assessed whether rec-YidRv could successfully trigger the proliferation of splenocytes and the synthesis of their cytokines. Furthermore, the capacity of antigen to protect mice from ESBL-producing KP strain infection was investigated. Results: In vitro and in vivo analyses revealed that mice immunized with rec-YidRv generated a strong antibody and memory response. Compared to non-stimulated controls, immunized mice showed an increase in measurable KP-directed immunoglobulin G (IgG) levels, with elevated IgG1 and IgG2b fractions; additionally, splenocyte proliferation expanded by 5-fold. Infection of mice with a lethal dose of KP following immunization markedly extended animal survival and decreased the pathogen’s ability to form ventricular biofilms. Conclusions: The rec-YidRv elicited robust antibody responses and a moderate expansion of cellular activity. Rec-YidRv is an effective protein-only platform for inhibiting infection by antibiotic-resistant KP. Future studies should incorporate refined adjuvants and improved administration methods to enhance protective responses.
- Open Access
- 27 February 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (2) , e1014019
An atypical venus fly trap domain receptor regulates motility and phagocytosis in the protozoan parasite Entamoeba histolytica
Amebiasis is a parasitic infection of the human intestines, primarily caused by Entamoeba histolytica . Its pathogenesis relies on the environmental sensing-induced cytoskeletal remodeling as the basic mechanism for motility and tissue invasion. We identified and characterized an atypical Venus Fly-Trap (VFT) receptor protein, Eh VFT (CL6EHI_096680). While it shares homology with the ligand-binding domain of class C GPCRs, it is phylogenetically related to the Periplasmic Binding Protein (PBP) superfamily. This protein is uniquely lacking a transmembrane domain. Instead, the glycosylphosphatidylinositol (GPI) anchor is responsible for its cell membrane localization. Removal of the GPI signal led to unexpected mitosomal localization, highlighting the importance of GPI modification in subcellular targeting. Functional studies revealed that Eh VFT knockdown reduced parasite motility and phagocytosis of mammalian cells following the reduction of expression of actin cytoskeleton-related genes, including myosin II, villidin, and gelsolin. Our findings suggest that Eh VFT plays a role in regulating downstream signaling linked to Entamoeba motility and phagocytosis. This study provides novel insights into an atypical VFT protein in E. histolytica , an area previously understudied.
- 27 February 2026
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (2) , e1014019
Open AccessAn atypical venus fly trap domain receptor regulates motility and phagocytosis in the protozoan parasite Entamoeba histolytica
Amebiasis is a parasitic infection of the human intestines, primarily caused by Entamoeba histolytica . Its pathogenesis relies on the environmental sensing-induced cytoskeletal remodeling as the basic mechanism for motility and tissue invasion. We identified and characterized an atypical Venus Fly-Trap (VFT) receptor protein, Eh VFT (CL6EHI_096680). While it shares homology with the ligand-binding domain of class C GPCRs, it is phylogenetically related to the Periplasmic Binding Protein (PBP) superfamily. This protein is uniquely lacking a transmembrane domain. Instead, the glycosylphosphatidylinositol (GPI) anchor is responsible for its cell membrane localization. Removal of the GPI signal led to unexpected mitosomal localization, highlighting the importance of GPI modification in subcellular targeting. Functional studies revealed that Eh VFT knockdown reduced parasite motility and phagocytosis of mammalian cells following the reduction of expression of actin cytoskeleton-related genes, including myosin II, villidin, and gelsolin. Our findings suggest that Eh VFT plays a role in regulating downstream signaling linked to Entamoeba motility and phagocytosis. This study provides novel insights into an atypical VFT protein in E. histolytica , an area previously understudied.
- Open Access
- 1 November 2022
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 10 (6) , 1139-1148
Potential of polyether ionophore compounds as antimalarials through inhibition on Plasmodium falciparum glutathione S-transferase by molecular docking studies
Context: Malaria is still a serious global health problem due to the development of drug resistance. It is necessary to find new drugs with renewable mechanisms that are effective in killing parasites. Our previous research has analyzed more than one compound of polyether ionophore group in ethyl acetate Streptomyces hygroscopicus subsp. hygroscopicus extract. Polyether ionophore is known to have a similar mechanism of action to chloroquine which is potent in inhibiting Plasmodium falciparum glutathione S-transferase (PfGST). Aims: To evaluate the potential effect of polyether ionophore toward PfGST as a target protein through molecular docking. Methods: PfGST was obtained from Protein Data Bank. Test ligands (polyether ionophore) and control ligands (chloroquine) were obtained from PubChem. Pharmacokinetic analysis was done using SwissADME, molecular docking using PyRx 0.9, visualization using LigPlot and PyMOL, and molecular dynamics using YASARA for the best ligand activity. Results: Lenoremycin had the highest binding affinity to PfGST (-8.53 kcal/mol) among other polyether ionophores, and nigericin had the best residue bonding with hydrophobic and hydrogen with a binding affinity of-8.25 kcal/mol compared to chloroquine complex in molecular docking and molecular dynamic simulation. Conclusions: Polyether ionophore could serve as an antimalarial agent better than chloroquine, with nigericin as the best compound candidate in inhibiting PfGST compared to other polyether ionophores.
- 1 November 2022
- Published by Garval Editorial Ltda. in Journal of Pharmacy & Pharmacognosy Research
- Vol. 10 (6) , 1139-1148
Open AccessPotential of polyether ionophore compounds as antimalarials through inhibition on Plasmodium falciparum glutathione S-transferase by molecular docking studies
Context: Malaria is still a serious global health problem due to the development of drug resistance. It is necessary to find new drugs with renewable mechanisms that are effective in killing parasites. Our previous research has analyzed more than one compound of polyether ionophore group in ethyl acetate Streptomyces hygroscopicus subsp. hygroscopicus extract. Polyether ionophore is known to have a similar mechanism of action to chloroquine which is potent in inhibiting Plasmodium falciparum glutathione S-transferase (PfGST). Aims: To evaluate the potential effect of polyether ionophore toward PfGST as a target protein through molecular docking. Methods: PfGST was obtained from Protein Data Bank. Test ligands (polyether ionophore) and control ligands (chloroquine) were obtained from PubChem. Pharmacokinetic analysis was done using SwissADME, molecular docking using PyRx 0.9, visualization using LigPlot and PyMOL, and molecular dynamics using YASARA for the best ligand activity. Results: Lenoremycin had the highest binding affinity to PfGST (-8.53 kcal/mol) among other polyether ionophores, and nigericin had the best residue bonding with hydrophobic and hydrogen with a binding affinity of-8.25 kcal/mol compared to chloroquine complex in molecular docking and molecular dynamic simulation. Conclusions: Polyether ionophore could serve as an antimalarial agent better than chloroquine, with nigericin as the best compound candidate in inhibiting PfGST compared to other polyether ionophores.
- 7 March 2022
- Published by Elsevier in Trends in Parasitology
- Vol. 38 (6) , 462-477
Physiological roles and metabolism of γ-aminobutyric acid (GABA) in parasitic protozoa
- 7 March 2022
- Published by Elsevier in Trends in Parasitology
- Vol. 38 (6) , 462-477
Physiological roles and metabolism of γ-aminobutyric acid (GABA) in parasitic protozoa
- Top Cited PapersOpen Access
- 4 March 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (4) , e24314
Malaria diagnostic update: From conventional to advanced method
Background: Update diagnostic methods play essential roles in dealing with the current global malaria situation and decreasing malaria incidence.Aim: Global malaria control programs require the availability of adequate laboratory tests in the quick and convenient field.Results: There are several methods to find out the existence of parasites within the blood. The oldest one is by microscopy, which is still a gold standard, although rapid diagnostic tests (RDTs) have rapidly become a primary diagnostic test in many endemic areas. Because of microscopy and RDTs limitation, novel serological and molecular methods have been developed. Many kinds of polymerase chain reaction (PCR) provide rapid results and higher specificity and sensitivity. The loop‐mediated isothermal amplification (LAMP) and biosensing‐based molecular techniques as point of care tests (POCT) will become a cost‐effective approach to advance diagnostic testing.Conclusion: Despite conventional techniques are still being used in the field, the exploration and field implementation of advanced techniques for the diagnosis of malaria are still being developed rapidly.
- 4 March 2022
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 36 (4) , e24314
Top Cited PapersOpen AccessMalaria diagnostic update: From conventional to advanced method
Background: Update diagnostic methods play essential roles in dealing with the current global malaria situation and decreasing malaria incidence.Aim: Global malaria control programs require the availability of adequate laboratory tests in the quick and convenient field.Results: There are several methods to find out the existence of parasites within the blood. The oldest one is by microscopy, which is still a gold standard, although rapid diagnostic tests (RDTs) have rapidly become a primary diagnostic test in many endemic areas. Because of microscopy and RDTs limitation, novel serological and molecular methods have been developed. Many kinds of polymerase chain reaction (PCR) provide rapid results and higher specificity and sensitivity. The loop‐mediated isothermal amplification (LAMP) and biosensing‐based molecular techniques as point of care tests (POCT) will become a cost‐effective approach to advance diagnostic testing.Conclusion: Despite conventional techniques are still being used in the field, the exploration and field implementation of advanced techniques for the diagnosis of malaria are still being developed rapidly.
- Open Access
- 27 February 2021
- Published by Brawijaya University in Jurnal Kedokteran Brawijaya
- Vol. 31 (3) , 186-192
Optimation of Combination of N-Hexane Solution and Ethyle Acetate on Secondary Metabolite Compounds Profile of Streptomyces hygroscopicus
Streptomyces hygroscopicus (S.hygroscopicus) is a Gram-positive soil bacterium that can produce secondary metabolites from fermentation that have a therapeutic effect. The fermented S. hygrocospicus metabolites that are still in the form of crude extracts are difficult to develop as drug preparations because the active compounds are not yet known, so it will be challenging to determine the dosage of drugs that have a therapeutic effect. Therefore, it is necessary to carry out exploratory research to narrow down the secondary metabolite profile from the fermentation of S. hygroscopicus, using extraction and fractionation methods, which are then identified by Thin-Layer Chromatography (TLC) using a combination of solvents. This study used the extraction method with a separating funnel. The fractionation was carried out using the BUCHI (Sepacore®) Flash Chromatography and Reveleris® PREP Purification System column chromatography gradually using ethyl acetate and n-hexana. 47 and 60 of the fractionation results were taken as samples, that further were profiled using TLC and given the appearance of 10% KOH stains and p-Anisaldehyde - sulfuric acid, so that various classes of compounds with different Rf values were obtained, namely Monoterpenes, Triterpenes, Steroids, Saponins, Coumarin, Scopoletin, and Alkaloids.
- 27 February 2021
- Published by Brawijaya University in Jurnal Kedokteran Brawijaya
- Vol. 31 (3) , 186-192
Open AccessOptimation of Combination of N-Hexane Solution and Ethyle Acetate on Secondary Metabolite Compounds Profile of Streptomyces hygroscopicus
Streptomyces hygroscopicus (S.hygroscopicus) is a Gram-positive soil bacterium that can produce secondary metabolites from fermentation that have a therapeutic effect. The fermented S. hygrocospicus metabolites that are still in the form of crude extracts are difficult to develop as drug preparations because the active compounds are not yet known, so it will be challenging to determine the dosage of drugs that have a therapeutic effect. Therefore, it is necessary to carry out exploratory research to narrow down the secondary metabolite profile from the fermentation of S. hygroscopicus, using extraction and fractionation methods, which are then identified by Thin-Layer Chromatography (TLC) using a combination of solvents. This study used the extraction method with a separating funnel. The fractionation was carried out using the BUCHI (Sepacore®) Flash Chromatography and Reveleris® PREP Purification System column chromatography gradually using ethyl acetate and n-hexana. 47 and 60 of the fractionation results were taken as samples, that further were profiled using TLC and given the appearance of 10% KOH stains and p-Anisaldehyde - sulfuric acid, so that various classes of compounds with different Rf values were obtained, namely Monoterpenes, Triterpenes, Steroids, Saponins, Coumarin, Scopoletin, and Alkaloids.
- Open Access
- 9 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 6135696
Antimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach
Malaria is one of the life‐threatening diseases in the world. The spread of resistance to antimalarial drugs is a major challenge, and resistance to artemisinin has been reported in the Southeast Asian region. In the previous study, the active compound of Streptomyces hygroscopicus subsp. Hygroscopicus (S. hygroscopicus), eponemycin, has been shown to have antimalarial effects. To further analyze the effects of other active compounds on the Plasmodium parasite, identifying and analyzing the effectiveness of compounds contained in S. hygroscopicus through instrumentation of liquid chromatography/mass spectrometry (LC/MS) and in silico studies were very useful. This study aimed at identifying other derivative compounds from S. hygroscopicus and screening the antimalarial activity of the compound by assessing the binding affinity, pharmacokinetic profile, and bond interaction. The derivative compounds were identified using LC/MS. Protein targets for derivative compounds were found through literature studies, and the results of identification of compounds and protein targets were reconstructed into three‐dimensional models. Prediction of pharmacokinetic profiles was carried out using Swiss ADME. Screening of protein targets for the derivative compound was carried out using the reverse molecular docking method. Analyzing bond interaction was done by LigPlot. One compound from S. hygroscopicus, i.e., 6,7‐dinitro‐2‐[1, 2, 4]triazole‐4‐yl‐benzo[de]isoquinoline‐1,3‐dione, was successfully identified using LC/MS. This compound was an isoquinoline derivative compound. Through literature studies with inclusion criteria, thirteen protein targets were obtained for reverse molecular docking. This isoquinoline derivative had the potential to bind to each protein target. The pharmacokinetic profile showed that this compound had the drug‐likeness criteria. Conclusion. 6,7‐Dinitro‐2‐[1, 2, 4]triazole‐4‐yl‐benzo[de]isoquinoline‐1,3‐dione has antimalarial activity as shown by reverse molecular docking studies and pharmacokinetic profiles. The best inhibitory ability of compounds based on bond affinity is with adenylosuccinate synthetase.
- 9 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 6135696
Open AccessAntimalarial Properties of Isoquinoline Derivative from Streptomyces hygroscopicus subsp. Hygroscopicus: An In Silico Approach
Malaria is one of the life‐threatening diseases in the world. The spread of resistance to antimalarial drugs is a major challenge, and resistance to artemisinin has been reported in the Southeast Asian region. In the previous study, the active compound of Streptomyces hygroscopicus subsp. Hygroscopicus (S. hygroscopicus), eponemycin, has been shown to have antimalarial effects. To further analyze the effects of other active compounds on the Plasmodium parasite, identifying and analyzing the effectiveness of compounds contained in S. hygroscopicus through instrumentation of liquid chromatography/mass spectrometry (LC/MS) and in silico studies were very useful. This study aimed at identifying other derivative compounds from S. hygroscopicus and screening the antimalarial activity of the compound by assessing the binding affinity, pharmacokinetic profile, and bond interaction. The derivative compounds were identified using LC/MS. Protein targets for derivative compounds were found through literature studies, and the results of identification of compounds and protein targets were reconstructed into three‐dimensional models. Prediction of pharmacokinetic profiles was carried out using Swiss ADME. Screening of protein targets for the derivative compound was carried out using the reverse molecular docking method. Analyzing bond interaction was done by LigPlot. One compound from S. hygroscopicus, i.e., 6,7‐dinitro‐2‐[1, 2, 4]triazole‐4‐yl‐benzo[de]isoquinoline‐1,3‐dione, was successfully identified using LC/MS. This compound was an isoquinoline derivative compound. Through literature studies with inclusion criteria, thirteen protein targets were obtained for reverse molecular docking. This isoquinoline derivative had the potential to bind to each protein target. The pharmacokinetic profile showed that this compound had the drug‐likeness criteria. Conclusion. 6,7‐Dinitro‐2‐[1, 2, 4]triazole‐4‐yl‐benzo[de]isoquinoline‐1,3‐dione has antimalarial activity as shown by reverse molecular docking studies and pharmacokinetic profiles. The best inhibitory ability of compounds based on bond affinity is with adenylosuccinate synthetase.